clinical trial registry shows that thousands of studies on GLP-1 receptor agonists are underway now
Research in some areas remains inconclusive, but many therapeutic uses are already well-established
It also lowers the risk of major cardiovascular events such as stroke, heart attack, or death in adults with type 2 diabetes who also have heart disease, and lowers the risk of worsening kidney disease, kidney failure (end-stage kidney disease), and death due to cardiovascular disease in adults with type 2 diabetes who also have chronic kidney disease
Mounjaro is approved by the U.S
If youre comparing online GLP-1 programs, look for direct provider access, lab review, pharmacy transparency, and honest expectations